yingweiwo
  1. Home
  2. Products
  3. Signaling Pathways
  4. Apoptosis
  5. PD-1 PD-L1

PD-1 PD-L1

PD-1 PD-L1

PD-1 PD-L1 related products

Structure Cat No. Product Name CAS No. Product Description
(-)-JQ-1 V3676 (-)-JQ-1 1268524-71-5 JQ-1 is the (R)-Enantiomer of JQ1 or the stereoisomer of (+)-JQ1.
(D)-PPA 1 TFA V77385 (D)-PPA 1 TFA (D)-PPA 1 TFA is a hydrolytic D-peptide antagonist.
Antitumor agent-169 V88733 Antitumor agent-169 Antitumor agent-169 (Compound B3) is a dual inhibitor of PD-1/PD-L1 interaction and PARP7 with IC50 of 0.426 μM and 2.50 nM, respectively.
Antitumor agent-170 V88725 Antitumor agent-170 Antitumor agent-170 (Compound C6) exhibits inhibitory activity against PD-1/PD-L1 interaction and PARP7 with IC50 of 0.342 μM and 7.05 nM, respectively.
BMS-142 V115356 BMS-142 1675203-24-3 BMS-142 is a PDL1 inhibitor (IC50 = 96.7 nM) (kd = 13.2 nM).
BMS-8 V3256 BMS-8 1675201-90-7 BMS-8is a novel small molecule inhibitor of the PD-1 (Programmed death-1)/PD-L1 (Programmed death-ligand 1) protein/protein interaction with potential anticancer activities.
BMS-986189 V86960 BMS-986189 1629665-96-8 BMS-986189 is a macrocyclic peptide PD-L1 inhibitor (IC50: 1.03 nM) for cancer research.
BMSpep-57 hydrochloride V77194 BMSpep-57 hydrochloride BMSpep-57 HCl is a potent macrocyclic peptide inhibitor that can suppress PD-1/PD-L1 interaction with IC50 of 7.68 nM.
Cemavafusp V100278 Cemavafusp Cemavafusp is an anti-PD-L1 monoclonal antibody composed of a single-chain variable fragment, an antibody heavy chain, and a kappa antibody light chain.
CYP51/PD-L1-IN-2 V78904 CYP51/PD-L1-IN-2 3032386-58-3 CYP51/PD-L1-IN-2 (compound L20) is a quinazoline compound with antifungal activity.
CYP51/PD-L1-IN-3 V78665 CYP51/PD-L1-IN-3 3032386-59-4 CYP51/PD-L1-IN-3 (compound L21) is a quinazoline compound with antifungal activity.
Erfonrilimab V135212 Erfonrilimab 2367013-69-0 Erfonrilimab is a monoclonal antibody that targets PD-L1/CTLA-4.
GJ19 V136646 GJ19 3099808-68-8 GJ19 is a PD-L1 inhibitor with an IC50 value of 32.06 nM.
HBV/HDV-IN-2 V86966 HBV/HDV-IN-2 3034161-76-4 HBV/HDV-IN-2 (Compd 143) is an inhibitor of HBV, HDV and PD-1/PD-L1 with an EC50 of 35 nM for T cell activation.
HX009 V137646 HX009 HX009 is a bispecific antibody that targets PD1 and CD47, but its binding ability to CD47 is relatively weak.
IBI-363 V114480 IBI-363 IBI-363 is a PD-1/IL-2 bispecific antibody that blocks the PD-1/PD-L1 pathway and activates the IL-2 pathway.
Lomvastomig V86940 Lomvastomig Lomvastomig is a human IgG1 kappa monoclonal antibody against PDCD1/HAVCR2.
LY3415244 V139160 LY3415244 LY3415244 is a human bispecific antibody (bsAb) that targets B7-H1/PD-L1/CD274 and TIM-3/HAVCR2/CD366.
N-deacetylated BMS-202 V3255 N-deacetylated BMS-202 2310135-18-1 N-deacetylated BMS-202, the deacetylated product of BMS-202 (also known asPD1-PDL1 inhibitor 2,BMS 202, BMS202), is a inhibitor of the PD-1 (Programmed death- 1)/PD-Ll (Programmed death-ligand 1) protein/protein interaction with potential anticancer activities.
NPH16 V141598 NPH16 NPH16 is an orally effective PD-1/PD-L1 inhibitor with an IC50 value of 24.4 nM.
Contact Us
Tel: 1-708-310-1919 Fax: 1-708-557-7486 Email: [email protected] Frequently Asked Questions
Subscribe to our E-newsletter
Name
E-mail

Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved

linkedin facebook
Contact Us
Home Product Cart Member